GGrantIndex
← Search

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site: COVPN 3004 Boost

$1,382,804UM1FY2022AINIH

University Of Maryland Baltimore, Baltimore MD

Investigators

Linked publications, trials & patents

Abstract

Novavax CoVPN 3004 Adult and Pediatric Booster Administration Project Summary/Abstract: Novavax Adult and Pediatric booster To date, 485 adult and 29 pediatric participants have received the initial series of vaccinations, had associated follow-up visits, and participated in a blinded cross-over. We estimate 380 adult and 29 pediatric participants will be invited to receive booster dose of vaccine and participate in associated follow-up visits. Blood and other protocol-required specimens collected at theses visits will be processed, stored, and shipped per protocol. Data will be entered, and data queries will be resolved in a timely manner. Surveillance for illness visits will continue and with the advent of new variants, it is expected illness visits will increase following major holidays with a gradual reduction to follow.

View original record on NIH RePORTER →